BeiGene Ltd (FRA:49BA) Stock News, Headlines & Updates
BeiGene Ltd Stock News from GuruFocus
- 1
Jun 14, 2024
BeiGene to Present New Data from SEQUOIA Study Evaluating BRUKINSA® plus Venetoclax in High-Risk First-Line CLL/SLL at EHA2024
Business Wire • 6:00am
BeiGene and NewBridge Pharmaceuticals FZ LLC Mutually Agree to Conclude BRUKINSA® (Zanubrutinib) Partnership in the Middle East and Africa (MENA) Region
Business Wire • 7:00pm
Jun 04, 2024
BeiGene to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
Business Wire • 6:00am
May 24, 2024
BRUKINSA® Data at ASCO Underscore Differentiated Clinical Profile for Treatment of CLL and SLL
Business Wire • 6:00am
May 14, 2024
BeiGene Highlights New Hematology Portfolio and Pipeline Data at EHA2024
Business Wire • 4:00pm
May 09, 2024
Decoding BeiGene Ltd (BGNE): A Strategic SWOT Insight
GuruFocus Research • 11:05pm
Apr 26, 2024
BeiGene Demonstrates Global Progress in 2023 Responsible Business & Sustainability Report
Business Wire • 10:00am
Apr 24, 2024
Global Oncology Innovator BeiGene Highlights New Data across Hematology and Solid Tumor Portfolio at 2024 ASCO Annual Meeting
Business Wire • 4:00pm
Apr 23, 2024
- 1
Show
Entries
Headlines
Total 0- 1
No recent news